Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Modular Medical, Inc. (MODD : NSDQ)
 
 • Company Description   
Modular Medical Inc. is a development-stage company in the diabetes/insulin delivery space. Modular Medical Inc. is based in SAN DIEGO, CA.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.34 Daily Weekly Monthly
20 Day Moving Average: 525,374 shares
Shares Outstanding: 63.68 (millions)
Market Capitalization: $21.83 (millions)
Beta: 0.16
52 Week High: $1.56
52 Week Low: $0.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -32.60% -34.41%
12 Week -52.08% -53.09%
Year To Date -74.98% -78.36%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10470 Thornmint Road
-
SAN DIEGO,CA 92127
USA
ph: 858-800-3500
fax: -
info@modular-medical.com http://www.modularmedical.com
 
 • General Corporate Information   
Officers
James E. Besser - Chief Executive Officer
Paul DiPerna - Chairman; President and Chief Financial Officer
Duane DeSisto - Director
Steven Felsher - Director
Morgan C. Frank - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 60785L207
SIC: 3841
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/12/26
Share - Related Items
Shares Outstanding: 63.68
Most Recent Split Date: (:1)
Beta: 0.16
Market Capitalization: $21.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/12/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.16
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -16.67%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/25 - -202.07
06/30/25 - -185.60
03/31/25 - -178.13
ROA
09/30/25 - -166.97
06/30/25 - -158.95
03/31/25 - -151.42
Current Ratio
09/30/25 - 1.47
06/30/25 - 4.04
03/31/25 - 10.69
Quick Ratio
09/30/25 - 1.47
06/30/25 - 4.04
03/31/25 - 10.69
Operating Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Net Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Pre-Tax Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Book Value
09/30/25 - 0.16
06/30/25 - 0.22
03/31/25 - 0.42
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©